A 2019 pan-India pharmacy audit found that 35% of retail outlets lacked a qualified pharmacist. In 2022, over 3,000 pharmacies across India were issued show cause notices or license suspensions for violations, including unauthorized sale of Schedule H1 and narcotic drugs. Representative Image: FreePik
MedBound Blog

66 Hospital Pharmacies Under Scrutiny for Major Violations

Drug Control Administration Flags Serious Compliance Issues

MBT Desk

A recent enforcement campaign conducted by the Telangana State Drug Control Administration (TSDCA) has revealed serious defaults in 66 hospital-owned pharmacies within Hyderabad and surrounding districts. These pharmacies, within or within the precincts of major corporate hospitals, are now in the regulatory crosshairs for breaching important pharmaceutical norms.

Show Cause Notices Issued Across the Board

All 66 pharmacies found in the course of the inspection drive have been served with show cause notices by the TSDCA. The notices request an explanation for a range of irregularities and non-compliance matters, which are destined to result in further regulatory and legal action.

Common Violations: From missing bills to expired medicines

The violations found are reflective of pharmaceutical negligence. Violations include:

  • Issuance of drugs without a registered pharmacist's presence

  • Failure to maintain sales records and generate purchase receipts.

  • Non-maintenance of the required prescription and Schedule H1 drug registers

  • Sale of drugs without a valid prescription

  • Storing saleable and expired drugs together

  • Inadequate storage of temperature-sensitive (thermolabile) drugs

These behaviours may compromise patient safety and contravene major healthcare guidelines.

In Maharashtra, a 2023 inspection by the FDA found that 35% of hospital pharmacies failed to maintain Schedule H1 drug registers, with over 200 pharmacies fined.

Specific cases: Remedy Hospital and others taken by surprise

In Remedy Hospital, Kukatpally, the DCA confiscated medical devices valued at ₹70,000 (7 Biopro PRP kits) for various labelling irregularities. The devices had no valid manufacturing license number and different manufacturing dates, as well as sterilization information printed on the packaging. In addition, no records of purchase and sale were available.

While that was happening, Life Care Pharmacy in Medak had been stockpiling commercial drugs as well as doctors' samples, another obvious go against the norms.

Banned Drug Found at Gemcare Poulomi Hospital

Most alarmingly, SUGATAB MV2 FORTE, an illegal compound drug, was found at the pharmacy that comes under Gemcare Poulomi Hospitals in Dr. A.S. Rao Nagar, Kupra. Stockpiling illegal medicines is very dangerous both legally as well as health-wise.

What's next?

The TSDCA has made it explicit that there would be accountability. All pharmacies have to reply to show cause notices, and default in giving satisfactory replies may lead to suspension of license, penalties, or prosecution.

(Input from various sources)

(Rehash/Muhammad Faisal Arshad/MSM)

Building Blocks of Health: How to Shape Good Habits Early in Life

Therapist Held Hostage by a Patient Sues Sheriff, Employer, and Father

Antidepressant Withdrawal Less Severe Than Once Thought, New Research Shows

New Study: Aluminum in Vaccines Not Linked to Health Risks

UK’s Three-Parent IVF Leads to Eight Healthy Babies, Says New Study